Skin manifestations are connected to infiltrating pDCs and expression of IFN-regulated genes (75), and a large number of studies have shown that targeting the IFN system in patients with SLE improves the skin manifestations (75, –77) (see Figure 2). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.